DK1421944T3 - Antacid- og laksativtablet - Google Patents

Antacid- og laksativtablet

Info

Publication number
DK1421944T3
DK1421944T3 DK02745874T DK02745874T DK1421944T3 DK 1421944 T3 DK1421944 T3 DK 1421944T3 DK 02745874 T DK02745874 T DK 02745874T DK 02745874 T DK02745874 T DK 02745874T DK 1421944 T3 DK1421944 T3 DK 1421944T3
Authority
DK
Denmark
Prior art keywords
tablet
oxide particles
magnesium oxide
antacid
laxative
Prior art date
Application number
DK02745874T
Other languages
Danish (da)
English (en)
Inventor
Mitsuhiro Sofue
Isamu Kawamura
Shigeo Yamao
Hideaki Baba
Shiro Horie
Yoko Abe
Hisae Sofue
Original Assignee
Kyowa Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd
Application granted granted Critical
Publication of DK1421944T3 publication Critical patent/DK1421944T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02745874T 2001-08-27 2002-07-08 Antacid- og laksativtablet DK1421944T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001256421 2001-08-27
PCT/JP2002/006909 WO2003018034A1 (fr) 2001-08-27 2002-07-08 Comprimes antiacides et laxatifs

Publications (1)

Publication Number Publication Date
DK1421944T3 true DK1421944T3 (da) 2008-03-31

Family

ID=19084237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745874T DK1421944T3 (da) 2001-08-27 2002-07-08 Antacid- og laksativtablet

Country Status (18)

Country Link
US (1) US7147868B2 (no)
EP (1) EP1421944B1 (no)
KR (3) KR100972773B1 (no)
CN (1) CN1262278C (no)
AT (1) ATE380546T1 (no)
AU (1) AU2002318630B2 (no)
CA (1) CA2424554C (no)
DE (1) DE60224056T2 (no)
DK (1) DK1421944T3 (no)
ES (1) ES2296960T3 (no)
HK (1) HK1061641A1 (no)
MX (1) MXPA03003292A (no)
MY (1) MY134676A (no)
NO (1) NO333440B1 (no)
PT (1) PT1421944E (no)
RU (1) RU2284189C2 (no)
TW (1) TWI331044B (no)
WO (1) WO2003018034A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
US20060165759A1 (en) * 2005-01-27 2006-07-27 Warner-Lambert Company Llc Antacid lozenge containing micronized particles
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
WO2009057796A1 (ja) * 2007-10-29 2009-05-07 Kyowa Chemical Industry Co., Ltd. 緩下剤
AU2010218737B2 (en) * 2009-02-25 2014-07-31 Kyowa Chemical Industry Co., Ltd. Magnesium oxide granules
CA2758714C (en) * 2009-04-22 2016-08-02 Kyowa Chemical Industry Co., Ltd. Tablet and pestle therefor
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
AU2010293637B2 (en) * 2009-09-08 2015-12-03 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablet
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
CN102283861A (zh) * 2010-06-17 2011-12-21 杭州赛利药物研究所有限公司 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
PL395069A1 (pl) * 2011-05-31 2012-12-03 Warszawski Uniwersytet Medyczny Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
CN106029103B (zh) 2014-02-25 2021-12-31 神岛化学工业株式会社 医药用或食品添加用的氧化镁颗粒
CN108686222B (zh) * 2018-06-13 2021-03-19 合肥合源药业有限公司 瑞舒伐他汀钙组合物的制备方法
TWI724629B (zh) * 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑
CN111281855B (zh) * 2020-03-23 2021-09-24 乐普制药科技有限公司 一种雷贝拉唑肠溶片及其制备方法
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674148A5 (no) 1986-06-24 1990-05-15 Racz Istvan
JP2731854B2 (ja) * 1989-02-10 1998-03-25 協和化学工業株式会社 高耐水和性、高流動性酸化マグネシウムの製造方法
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
IT1250701B (it) 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JP2711614B2 (ja) * 1992-06-10 1998-02-10 新日本製鐵株式会社 皮膜特性及び磁気特性の優れた方向性電磁鋼板の製造方法
JPH0940561A (ja) * 1995-08-02 1997-02-10 Fujitsukusu Kk 瀉下剤
JPH10120416A (ja) * 1996-10-17 1998-05-12 Kyowa Chem Ind Co Ltd 水懸濁用水酸化マグネシウム粉末
JP2000001428A (ja) * 1998-04-16 2000-01-07 Nippon Shinyaku Co Ltd 錠剤及び製造法
JP2001048792A (ja) * 1998-11-26 2001-02-20 Fujix Kk 瀉下剤

Also Published As

Publication number Publication date
NO20031873L (no) 2003-04-25
KR20080099353A (ko) 2008-11-12
MY134676A (en) 2007-12-31
KR20040044385A (ko) 2004-05-28
RU2284189C2 (ru) 2006-09-27
MXPA03003292A (es) 2004-12-13
HK1061641A1 (en) 2004-09-30
ES2296960T3 (es) 2008-05-01
DE60224056T2 (de) 2008-12-04
DE60224056D1 (de) 2008-01-24
US20040022872A1 (en) 2004-02-05
EP1421944A1 (en) 2004-05-26
ATE380546T1 (de) 2007-12-15
TWI331044B (en) 2010-10-01
NO333440B1 (no) 2013-06-03
CA2424554A1 (en) 2003-03-06
CA2424554C (en) 2009-08-18
PT1421944E (pt) 2008-01-03
WO2003018034A1 (fr) 2003-03-06
NO20031873D0 (no) 2003-04-25
US7147868B2 (en) 2006-12-12
CN1262278C (zh) 2006-07-05
EP1421944B1 (en) 2007-12-12
AU2002318630B2 (en) 2007-05-17
KR20090065552A (ko) 2009-06-22
EP1421944A4 (en) 2005-08-31
CN1473049A (zh) 2004-02-04
KR100972773B1 (ko) 2010-07-30

Similar Documents

Publication Publication Date Title
DK1421944T3 (da) Antacid- og laksativtablet
HUP0003897A2 (hu) Pezsgő sav-bázis párt tartalmazó gyógyászati kompozíciók
DE69902046D1 (de) Neue feste dosisform enthaltend nanopartikelnaproxen
NZ548351A (en) Direct compression formulation and process
RU2004118709A (ru) Составы, содержащие азитромицин, поддающиеся прямому прессованию
AU5504599A (en) Quick release pharmaceutical compositions of drug substances
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
EA200400045A1 (ru) Система для ингаляции сухим порошком для транспульмонарного применения
BR0116556A (pt) Composição farmacêutica e seu uso, processo para tratamento ou prevenção de angina ou hipertensão ou falha cardìaca, processo para fazer a composição, processo e comprimido
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
RU2003112224A (ru) Антацидная и слабительная таблетка
MY127350A (en) Flash-melt oral dose formulations
UA86751C2 (ru) Дозированная форма ибупрофена натрия
ATE329582T1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
BR0306996A (pt) Composição detergente particulada
JPS61158923A (ja) アスコルビン酸顆粒の製造方法
TW200420230A (en) Packaged tea drink
RU2009118826A (ru) Эсциталопрам и твердая фармацевтическая композиция, его содержащая
WO2004000223A3 (en) Rapidly disintegrating formulations for treating or preventing mucositis
WO2003013441A3 (en) Levothyroxine compositions and methods
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
ATE376827T1 (de) Solid darreichungsform enthaltend koffein
AU2011273595A1 (en) Compositions with a high active ingredient fraction of a mixture of chondroitin sulphate and glucosamine
MX2021009025A (es) Tableta bucodispersable.
ES2155241T3 (es) Agente antiestatico para composiciones de polimeros.